Invesco Ltd.

Position in ALXO — Alx Oncology Holdings Inc

CIK 914208 Atlanta, GA

Position in ALXO

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$22,014

-$23,984 QoQ

Shares Held

10,980

-85.1% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#53

of 68 holders

Holding Since

Mar 2021

9 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Invesco Ltd. holds $8,193,805,089 across 258 Biotechnology names. ALXO ranks #258 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,724,478	$1,332,400,669
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,561,057	$1,143,614,384
3	ARGX	Argenx SE	594,697	$434,277,482
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,291,726	$427,393,371
5	INCY	Incyte Corp	3,870,764	$364,316,298
6	BBIO	BridgeBio Pharma, Inc.	4,592,814	$341,062,362
7	INSM	INSMED Inc	1,988,968	$325,236,040
8	HALO	Halozyme Therapeutics, Inc.	4,012,494	$259,327,483

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$22,014	10,980	-85.1%	Shares	Defined	2026-05-12
2025-03-31	$45,998	73,836	+617.6%	Shares	Defined	2025-05-12
2024-06-30	$62,048	10,290	-97.3%	Shares	Defined	2024-08-13
2023-12-31	$5,736,103	385,232	-40.1%	Shares	Defined	2024-02-13
2022-03-31	$10,874,929	643,487	+2.2%	Shares	Defined	2022-05-16
2021-12-31	$13,537,022	629,922	+22.4%	Shares	Defined	2022-02-14
2021-09-30	$38,024,233	514,815	+6841.9%	Shares	Defined	2021-11-15
2021-06-30	$405,505	7,416	+132.4%	Shares	Defined	2021-08-17
2021-03-31	$235,303	3,191	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.